| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 3,235,000 | 3,194,000 | 3,431,000 | 3,643,000 | | Cost of Revenue | 4,275,000 | 1,071,000 | 1,440,000 | 5,693,000 | | | Gross Profit | (1,040,000) | 2,123,000 | 1,991,000 | (2,050,000) | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | (2,096,000) | 1,037,000 | 1,059,000 | (3,010,000) | | Non Recurring |
-
|
-
|
-
|
-
| | Others | 450,000 | 429,000 | 419,000 | 410,000 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 606,000 | 657,000 | 513,000 | 550,000 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 28,000 | 32,000 | 30,000 | 51,000 | | Earnings Before Interest And Taxes | 634,000 | 689,000 | 543,000 | 601,000 | | Interest Expense | 194,000 | 166,000 | 173,000 | 148,000 | | Income Before Tax | 440,000 | 523,000 | 370,000 | 453,000 | | Income Tax Expense | 113,000 | 132,000 | 131,000 | 75,000 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 327,000 | 391,000 | 239,000 | 378,000 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 327,000 | 391,000 | 239,000 | 378,000 | | Preferred Stock And Other Adjustments | (3,000) | (4,000) | (3,000) | (14,000) | | | Net Income Applicable To Common Shares | $324,000 | $387,000 | $236,000 | $364,000 |
|
0.02% Nasdaq 0.00%
Income Statement
